Covance   2Q Revenues: $644.0 (+10%) 2Q Earnings: $41.0 million (loss of $12.7 million 2Q12) YTD Revenues: $1.3 billion (+10%) YTD Earnings: $89.2 million (+287%) Comments: Late-Stage development revenue grew 17% to $378 million in the quarter, driven by central lab services. Early Development revenue was flat at $215 million. Clinical development was up 13% in the quarter and delivered record adjusted orders of $776 million in the quarter, resulting in an adjusted book-to-bill of 1.31 to 1....